Savara
SVRA
#6197
Rank
โ‚ฌ0.92 B
Marketcap
4,21ย โ‚ฌ
Share price
-1.69%
Change (1 day)
16.50%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -โ‚ฌ0.13 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ0.11 Billion a decrease over its 2024 earnings that were of -โ‚ฌ86.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.13 Billion11.42%
2025 -โ‚ฌ0.11 Billion23.94%
2024 -โ‚ฌ86.97 Million75.29%
2023 -โ‚ฌ49.62 Million43.38%
2022 -โ‚ฌ34.61 Million-11.31%
2021 -โ‚ฌ39.02 Million-13.3%
2020 -โ‚ฌ45 Million-36.53%
2019 -โ‚ฌ70.91 Million13.76%
2018 -โ‚ฌ62.33 Million105.54%
2017 -โ‚ฌ30.33 Million34.11%
2016 -โ‚ฌ22.62 Million-37.43%
2015 -โ‚ฌ36.14 Million38.81%
2014 -โ‚ฌ26.04 Million33.62%
2013 -โ‚ฌ19.49 Million38.49%
2012 -โ‚ฌ14.07 Million24.59%
2011 -โ‚ฌ11.3 Million-36.5%
2010 -โ‚ฌ17.79 Million-3.14%
2009 -โ‚ฌ18.36 Million-23.28%
2008 -โ‚ฌ23.93 Million8.52%
2007 -โ‚ฌ22.06 Million-34.14%
2006 -โ‚ฌ33.49 Million184.43%
2005 -โ‚ฌ11.78 Million90.75%
2004 -โ‚ฌ6.18 Million190.35%
2003 -โ‚ฌ2.13 Million11.64%
2002 -โ‚ฌ1.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.47 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA